Results 241 to 250 of about 2,107,565 (334)

Immunotherapy in Peanut Allergy: The Present and the Future. [PDF]

Allergy Asthma Immunol Res
Ahn K.
europepmc   +1 more source

Neurobiologic Advances from the Brain Disease Model of Addiction.

New England Journal of Medicine, 2016
D. Longo, N. Volkow, G. Koob, A. Mclellan   +3 more
semanticscholar   +1 more source

Laboratory approaches in desensitization for ABO-incompatible transplantation. [PDF]

Clin Transplant Res
Shin KH, Lee HJ.
europepmc   +1 more source

Rituximab and intravenous immune globulin for desensitization during renal transplantation.

New England Journal of Medicine, 2008
A. Vo, M. Lukovsky, M. Toyoda, Jennifer P. Wang, N. Reinsmoen, Chih‐hung Lai, A. Peng, R. Villicana, S. Jordan   +8 more
semanticscholar   +1 more source

Microscopic and molecular aspects of skeletal muscle alterations in cerebral palsy

Developmental Medicine &Child Neurology, EarlyView.
Cerebral palsy, caused by non‐progressive brain injury, is frequently accompanied by skeletal muscle alterations. This review synthesizes current evidence from muscle biopsy studies, revealing cellular and molecular adaptations in muscle tissue. Abstract Cerebral palsy (CP), the most prevalent childhood‐onset motor disability, frequently entails ...
Sebastian Edman, Oscar Horwath, Eva Pontén, Sudarshan Dayanidhi, Ferdinand von Walden   +4 more
wiley   +1 more source

Desensitization With Imlifidase: Overcoming Immunological Barriers in Kidney Transplantation. [PDF]

Kidney Med
Hernández-Velasco PJ, Gutiérrez Martínez E, Polanco Fernández N, González Monte ME, González-García C, Mancebo Sierra E, Andrés Belmonte A.   +6 more
europepmc   +1 more source

Effects of eye movement desensitization and reprocessing (EMDR) treatment in chronic pain patients: a systematic review.

Pain medicine (Malden, Mass.), 2014
J. Tesarz, S. Leisner, A. Gerhardt, S. Janke, G. Seidler, W. Eich, M. Hartmann   +6 more
semanticscholar   +1 more source

Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease

Epilepsia, EarlyView.
Abstract Background and Objective Lafora disease (LD) is a rare progressive disorder caused by mutations in the EPM2A or EPM2B genes, characterized by the accumulation of Lafora bodies, drug‐resistant epilepsy, and cognitive decline. To investigate the early molecular mechanisms of LD, we studied electrophysiological changes in the dentate gyrus (DG ...
Cinzia Costa, Laura Bellingacci, Jacopo Canonichesi, Valentina Imperatore, Anna Aurora Taddei, Luis Zafra‐Puerta, Nerea Iglesias‐Cabeza, Paolo Prontera, Andrea Mancini, Massimiliano Di Filippo, Alessandro Tozzi, Katiuscia Martinello, Marta Barzasi, Fabrizio Gardoni, Marina P. Sánchez, José M. Serratosa, Lucilla Parnetti, Miriam Sciaccaluga   +17 more
wiley   +1 more source

Pharmacological Insights into Optimal Dosing in Burning Mouth Syndrome: A Narrative Review of the Non-Linear Actions of Amitriptyline and Aripiprazole. [PDF]

J Clin Med
Nagamine T.
europepmc   +1 more source

Management of an uncommon complication using botulinum toxin type A following prosthetic laryngoplasty

Equine Veterinary Education, EarlyView.
Summary An uncommon complication following prosthetic laryngoplasty was reported in a 4‐year‐old Andalusian mare. The mare was presented with a previously diagnosed left‐sided recurrent laryngeal neuropathy, after initial evaluation the mare underwent ventriculocordectomy and prosthetic laryngoplasty.
J. L. Sanclemente, D. S. Larriva, C. A. Ragle   +2 more
wiley   +1 more source